<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02506673</url>
  </required_header>
  <id_info>
    <org_study_id>2014-394</org_study_id>
    <nct_id>NCT02506673</nct_id>
  </id_info>
  <brief_title>Audiovisual Aid Pilot Study</brief_title>
  <official_title>The Effect of Audiovisual Aids on Perioperative Stress Response, Pain and Overall Experience - a Randomized Controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Little is known about perioperative stress responses and possible anxiety mitigating factors
      like audiovisual aids or IV sedation. Most studies use surrogate markers and retrospective
      questionnaires, and are not based on real-time gathered data. Skin conductance measurements
      allow the sympathetic discharge to be evaluated down to fractions of a second and enable us
      to continuously monitor stress responses as skin conductance responses/per second during the
      perioperative management. In our study, the investigators propose to examine the effect of
      personal audiovisual equipment (audio/video goggles) on perioperative stress, pain, and
      overall experience in patients undergoing ambulatory meniscectomy under spinal anesthesia.
      Patients will be randomly assigned to either receive traditional sedation or light sedation
      in addition to audiovisual equipment. The investigators hope to determine outcome estimates
      of the use of this equipment on stress levels using skin conductance measurements, request
      for further sedation, postoperative pain levels and analgesic consumption, time to discharge
      readiness, and overall patient satisfaction, and collect thus far unavailable data on the
      stress response to perioperative stresses (such as IV insertion and spinal placement) in
      order to allow for power analyses for future studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PLEASE NOTE: After conducting the interim analysis and plotting the skin conductance data, we
      have determined that the graphs are not consistent enough to draw any conclusions. Given the
      technical difficulties we have encountered with the Med-Storm Stress Detector, as well as the
      labor intensity associated with it, we have decided that we will no longer use it from
      patient 14 on. We will not mark the time points and hand movements described in the protocol,
      as this data was used to understand the skin conductance data. We will continue to enroll
      patients to complete this pilot/exploratory study, as the other secondary outcomes--in
      particular, the surveys--could provide valuable information.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 14, 2016</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Conductance Response</measure>
    <time_frame>Measured in 5 minute intervals, from holding area until PACU discharge.</time_frame>
    <description>Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beats Per Minute (BPM)</measure>
    <time_frame>Measured from preop to postop</time_frame>
    <description>The change in heart rate from holding area until PACU discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic and Diastolic Blood Pressure</measure>
    <time_frame>Measured from preop to postop</time_frame>
    <description>The maximum change in postoperative systolic and diastolic blood pressure from holding area until PACU discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Measured from preop to postop</time_frame>
    <description>The maxmimum change in postoperative respiratory rate from holding area until PACU discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Who Requested Additional Sedation</measure>
    <time_frame>In the operating room</time_frame>
    <description>Number of patients who requested additional sedative medication in the operating room.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Numerical Rating Scale (NRS) Levels</measure>
    <time_frame>Holding area, Postop (PACU, 30 minutes after arrival to PACU and POD1)</time_frame>
    <description>Pain scores at rest will be collected from patients using the numerical rating scale (NRS), which asks patients to report their level of pain on a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. NRS levels in holding area, PACU until discharge from the PACU and one day after surgery, postop day 1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Narcotic Consumption</measure>
    <time_frame>Preop until 24 hours after surgery (holding area until POD 1)</time_frame>
    <description>Narcotic consumption &quot;intraop&quot;, &quot;postop&quot; and &quot;POD1&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory Questionnaire (STAI)</measure>
    <time_frame>holding area and PACU</time_frame>
    <description>Questionnaire to measure state anixety levels based on a 4-point likert scale and consists of 40 questions. The questionnaire measures two types of anxiety: state anxiety and trait anxiety. State anxiety relates to anxiety about an event, while trait anxiety in anxiety level as a personal characteristic. Scores can range from 20 to 80 and higher scores correlate with more anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heidelberg Peri-anaesthetic Questionnaire</measure>
    <time_frame>At PACU upon spinal resolution.</time_frame>
    <description>The questionnaire consists of 38 questions assessing perioperative satisfaction about five identified themes: trust and atmosphere; fear; discomfort; treatment by personnel; and information and waiting. The questions are rated on a 4-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Higher scores indicate higher levels of satisfaction. Patient satisfaction (Heidelberg Peri-Anaesthetic Questionnaire) in PACU upon spinal resolution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Client Satisfaction Questionnaire (CSQ-8)</measure>
    <time_frame>PACU upon spinal resolution</time_frame>
    <description>The client satisfaction questionnaire (CSQ-8) is a standardized satisfaction measure and was used to collect patient feedback on the audio visual devices. Response options differ, but all are on a 4-point scale. Scores range from 8 to 32, with higher values indicating higher satisfaction. Patient feedback (CSQ8) in PACU upon spinal resolution provider feedback (form sent to providers at end of surgery day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids</measure>
    <time_frame>Sent to providers at end of surgery.</time_frame>
    <description>Anesthesia providers were asked to provide feedback on their experience with the audio-visual aids when the randomization was for the use of the device. This was collected upon surgery end.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Request of Sedation/Termination of AVA</measure>
    <time_frame>From consent until spinal resolution (avg 6 hs)</time_frame>
    <description>Request of Sedation/Termination of AVA (After consent has been obtained until spinal resolution in the recovery room, average of 6 hours)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Complications</measure>
    <time_frame>Intraoperatively and in the recovery room, average of 3 hours</time_frame>
    <description>The percentage of patients who experienced complications (headache, transient neurologic symptoms, nausea and vomiting, ...)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Stress, Psychological</condition>
  <arm_group>
    <arm_group_label>Sedation only with skin conductance monitor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedation &amp; audiovisual aids with skin conductance monitor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zeiss, Cinema ProMED (audiovisual equipment)</intervention_name>
    <arm_group_label>Sedation &amp; audiovisual aids with skin conductance monitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <arm_group_label>Sedation &amp; audiovisual aids with skin conductance monitor</arm_group_label>
    <arm_group_label>Sedation only with skin conductance monitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Skin Conductance Monitor</intervention_name>
    <arm_group_label>Sedation &amp; audiovisual aids with skin conductance monitor</arm_group_label>
    <arm_group_label>Sedation only with skin conductance monitor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for primary, ambulatory, arthroscopic meniscectomy under spinal
             anesthesia

        Exclusion Criteria:

          -  Patients with psychiatric disease and those on antidepressants

          -  Contraindications to spinal anesthesia or allergy to study medication

          -  Age &lt; 18 years

          -  Patients with audiovisual impairments

          -  Patients with inability to communicate in English or understand the study requirements

          -  Chronic pain patients +/- opioid use

          -  Patients with (neuro)dermatoses encompassing the hand

          -  Patients with pacemakers

          -  Patients with diabetes or known neuropathic disease

          -  Patients with a history of epilepsy or seizure disorder

          -  Patients with a history of claustrophobia

          -  Patients with a history of epilepsy

          -  Patients with prior history of epilepsy or seizure disorder

          -  Patients undergoing a revision or open procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stavros G. Memtsoudis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital for Special Surgery (HSS)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 2, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2015</study_first_posted>
  <results_first_submitted>September 7, 2018</results_first_submitted>
  <results_first_submitted_qc>February 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 10, 2020</results_first_posted>
  <last_update_submitted>February 3, 2020</last_update_submitted>
  <last_update_submitted_qc>February 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Audiovisual Aids</keyword>
  <keyword>Perioperative Period</keyword>
  <keyword>Anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 18, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT02506673/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sedation Only With Skin Conductance Monitor</title>
          <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
        </group>
        <group group_id="P2">
          <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
          <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sedation Only With Skin Conductance Monitor</title>
          <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
        </group>
        <group group_id="B2">
          <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
          <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Skin Conductance Response</title>
        <description>Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU.</description>
        <time_frame>Measured in 5 minute intervals, from holding area until PACU discharge.</time_frame>
        <population>We had planned to use the Med-Storm Stress detector to measure skin conductance throughout the procedure until discharge. However, due to repeated technical difficulties with the device and inconclusive data from an analysis of a small number of patients data collection was stopped. No data are presented here.</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Skin Conductance Response</title>
          <description>Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU.</description>
          <population>We had planned to use the Med-Storm Stress detector to measure skin conductance throughout the procedure until discharge. However, due to repeated technical difficulties with the device and inconclusive data from an analysis of a small number of patients data collection was stopped. No data are presented here.</population>
          <units>skin conductance responses per second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" spread="NA">Due to repeated technical difficulties with the device and inconclusive data from the analysis, the data collection was stopped. There is no data to be presented here.</measurement>
                    <measurement group_id="O2" value="NA" spread="NA">Due to repeated technical difficulties with the device and inconclusive data from the analysis, the data collection was stopped. There is no data to be presented here.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Beats Per Minute (BPM)</title>
        <description>The change in heart rate from holding area until PACU discharge.</description>
        <time_frame>Measured from preop to postop</time_frame>
        <population>Baseline has the heart rate number but analysis for intraop and postop is the change of the variable. Some patients were discharge earlier</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Beats Per Minute (BPM)</title>
          <description>The change in heart rate from holding area until PACU discharge.</description>
          <population>Baseline has the heart rate number but analysis for intraop and postop is the change of the variable. Some patients were discharge earlier</population>
          <units>Beats Per Minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BPM Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.7" spread="10.2"/>
                    <measurement group_id="O2" value="66.8" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BPM change Intraop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" spread="27"/>
                    <measurement group_id="O2" value="17" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BPM change Postop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="10"/>
                    <measurement group_id="O2" value="-6" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic and Diastolic Blood Pressure</title>
        <description>The maximum change in postoperative systolic and diastolic blood pressure from holding area until PACU discharge.</description>
        <time_frame>Measured from preop to postop</time_frame>
        <population>Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) for baseline, intra op and post op was recorded.</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic and Diastolic Blood Pressure</title>
          <description>The maximum change in postoperative systolic and diastolic blood pressure from holding area until PACU discharge.</description>
          <population>Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) for baseline, intra op and post op was recorded.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="013"/>
                <count group_id="O2" value="013"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>DBP Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="013"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.8" spread="12.7"/>
                    <measurement group_id="O2" value="79.6" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP change intraop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="013"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="8"/>
                    <measurement group_id="O2" value="2" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DBP change postop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" spread="11"/>
                    <measurement group_id="O2" value="-4" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="013"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135.3" spread="14.5"/>
                    <measurement group_id="O2" value="129.2" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP change intraop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="013"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="10"/>
                    <measurement group_id="O2" value="7" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SBP change postop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8" spread="13"/>
                    <measurement group_id="O2" value="-2" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Rate</title>
        <description>The maxmimum change in postoperative respiratory rate from holding area until PACU discharge.</description>
        <time_frame>Measured from preop to postop</time_frame>
        <population>Some data was not available for all participants due to equipment not working or due to early discharge</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Rate</title>
          <description>The maxmimum change in postoperative respiratory rate from holding area until PACU discharge.</description>
          <population>Some data was not available for all participants due to equipment not working or due to early discharge</population>
          <units>breaths/minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="013"/>
                <count group_id="O2" value="013"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RR Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="013"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.2" spread="2.2"/>
                    <measurement group_id="O2" value="16.9" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RR change intraop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="12"/>
                    <measurement group_id="O2" value="4" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RR change postop</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" spread="3"/>
                    <measurement group_id="O2" value="1" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Who Requested Additional Sedation</title>
        <description>Number of patients who requested additional sedative medication in the operating room.</description>
        <time_frame>In the operating room</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Requested Additional Sedation</title>
          <description>Number of patients who requested additional sedative medication in the operating room.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Numerical Rating Scale (NRS) Levels</title>
        <description>Pain scores at rest will be collected from patients using the numerical rating scale (NRS), which asks patients to report their level of pain on a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. NRS levels in holding area, PACU until discharge from the PACU and one day after surgery, postop day 1.</description>
        <time_frame>Holding area, Postop (PACU, 30 minutes after arrival to PACU and POD1)</time_frame>
        <population>Holding area, PACU arrival, 30 minutes after arrival to PACU and POD1.</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Numerical Rating Scale (NRS) Levels</title>
          <description>Pain scores at rest will be collected from patients using the numerical rating scale (NRS), which asks patients to report their level of pain on a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. NRS levels in holding area, PACU until discharge from the PACU and one day after surgery, postop day 1.</description>
          <population>Holding area, PACU arrival, 30 minutes after arrival to PACU and POD1.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="013"/>
                <count group_id="O2" value="013"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Holding area</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="013"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="1.6"/>
                    <measurement group_id="O2" value="2.2" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU arrival</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes after arrival to PACU</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="2.2"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="013"/>
                    <count group_id="O2" value="010"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="1.7"/>
                    <measurement group_id="O2" value="2.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Narcotic Consumption</title>
        <description>Narcotic consumption &quot;intraop&quot;, &quot;postop&quot; and &quot;POD1&quot;</description>
        <time_frame>Preop until 24 hours after surgery (holding area until POD 1)</time_frame>
        <population>POD1 - 13 patients from the AVA group were analyzed due to early discharge.</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Narcotic Consumption</title>
          <description>Narcotic consumption &quot;intraop&quot;, &quot;postop&quot; and &quot;POD1&quot;</description>
          <population>POD1 - 13 patients from the AVA group were analyzed due to early discharge.</population>
          <units>oral morphine equivalents mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>OME mg Intraop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="8.3"/>
                    <measurement group_id="O2" value="3.5" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OME mg Inpatient postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8" spread="6"/>
                    <measurement group_id="O2" value="10.8" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OME mg POD1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.0" spread="9.9"/>
                    <measurement group_id="O2" value="11.5" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>State-Trait Anxiety Inventory Questionnaire (STAI)</title>
        <description>Questionnaire to measure state anixety levels based on a 4-point likert scale and consists of 40 questions. The questionnaire measures two types of anxiety: state anxiety and trait anxiety. State anxiety relates to anxiety about an event, while trait anxiety in anxiety level as a personal characteristic. Scores can range from 20 to 80 and higher scores correlate with more anxiety.</description>
        <time_frame>holding area and PACU</time_frame>
        <population>4-point likert scale and consists of 40 questions</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>State-Trait Anxiety Inventory Questionnaire (STAI)</title>
          <description>Questionnaire to measure state anixety levels based on a 4-point likert scale and consists of 40 questions. The questionnaire measures two types of anxiety: state anxiety and trait anxiety. State anxiety relates to anxiety about an event, while trait anxiety in anxiety level as a personal characteristic. Scores can range from 20 to 80 and higher scores correlate with more anxiety.</description>
          <population>4-point likert scale and consists of 40 questions</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>STAI-State in holding area</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.5" spread="11.4"/>
                    <measurement group_id="O2" value="32.3" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STAI-Trait in holding area</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.4" spread="8.9"/>
                    <measurement group_id="O2" value="31.8" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STAI-State in PACU</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.1" spread="2.6"/>
                    <measurement group_id="O2" value="27.1" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>STAI-Trait in PACU</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.3" spread="9.2"/>
                    <measurement group_id="O2" value="32.8" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heidelberg Peri-anaesthetic Questionnaire</title>
        <description>The questionnaire consists of 38 questions assessing perioperative satisfaction about five identified themes: trust and atmosphere; fear; discomfort; treatment by personnel; and information and waiting. The questions are rated on a 4-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Higher scores indicate higher levels of satisfaction. Patient satisfaction (Heidelberg Peri-Anaesthetic Questionnaire) in PACU upon spinal resolution.</description>
        <time_frame>At PACU upon spinal resolution.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Heidelberg Peri-anaesthetic Questionnaire</title>
          <description>The questionnaire consists of 38 questions assessing perioperative satisfaction about five identified themes: trust and atmosphere; fear; discomfort; treatment by personnel; and information and waiting. The questions are rated on a 4-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Higher scores indicate higher levels of satisfaction. Patient satisfaction (Heidelberg Peri-Anaesthetic Questionnaire) in PACU upon spinal resolution.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.2" spread="14.0"/>
                    <measurement group_id="O2" value="98.9" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Client Satisfaction Questionnaire (CSQ-8)</title>
        <description>The client satisfaction questionnaire (CSQ-8) is a standardized satisfaction measure and was used to collect patient feedback on the audio visual devices. Response options differ, but all are on a 4-point scale. Scores range from 8 to 32, with higher values indicating higher satisfaction. Patient feedback (CSQ8) in PACU upon spinal resolution provider feedback (form sent to providers at end of surgery day)</description>
        <time_frame>PACU upon spinal resolution</time_frame>
        <population>This questionnaire was only administered to patients who used the audio-visual aids</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Client Satisfaction Questionnaire (CSQ-8)</title>
          <description>The client satisfaction questionnaire (CSQ-8) is a standardized satisfaction measure and was used to collect patient feedback on the audio visual devices. Response options differ, but all are on a 4-point scale. Scores range from 8 to 32, with higher values indicating higher satisfaction. Patient feedback (CSQ8) in PACU upon spinal resolution provider feedback (form sent to providers at end of surgery day)</description>
          <population>This questionnaire was only administered to patients who used the audio-visual aids</population>
          <units>scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="31.5" lower_limit="27" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids</title>
        <description>Anesthesia providers were asked to provide feedback on their experience with the audio-visual aids when the randomization was for the use of the device. This was collected upon surgery end.</description>
        <time_frame>Sent to providers at end of surgery.</time_frame>
        <population>Providers were only asked to provide feedback on the equipment when used by patients in the audiovisual aid group upon surgery end.</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids</title>
          <description>Anesthesia providers were asked to provide feedback on their experience with the audio-visual aids when the randomization was for the use of the device. This was collected upon surgery end.</description>
          <population>Providers were only asked to provide feedback on the equipment when used by patients in the audiovisual aid group upon surgery end.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="011"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Request of Sedation/Termination of AVA</title>
        <description>Request of Sedation/Termination of AVA (After consent has been obtained until spinal resolution in the recovery room, average of 6 hours)</description>
        <time_frame>From consent until spinal resolution (avg 6 hs)</time_frame>
        <population>This outcome is only providing findings for subjects that has sedation and audiovisual aids with skin conductance monitor. It does not pertain to subjects that had sedation without the AVA.</population>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Request of Sedation/Termination of AVA</title>
          <description>Request of Sedation/Termination of AVA (After consent has been obtained until spinal resolution in the recovery room, average of 6 hours)</description>
          <population>This outcome is only providing findings for subjects that has sedation and audiovisual aids with skin conductance monitor. It does not pertain to subjects that had sedation without the AVA.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of Participants (AVA Randomization)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Request of Sedation/Termination of AVA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Complications</title>
        <description>The percentage of patients who experienced complications (headache, transient neurologic symptoms, nausea and vomiting, ...)</description>
        <time_frame>Intraoperatively and in the recovery room, average of 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sedation Only With Skin Conductance Monitor</title>
            <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
          </group>
          <group group_id="O2">
            <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
            <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Complications</title>
          <description>The percentage of patients who experienced complications (headache, transient neurologic symptoms, nausea and vomiting, ...)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Incidence of Complication Intraop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incidence of Complication PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data will be collected on the day of surgery in the holding area, during the procedure, in the PACU until discharge, and on post-operative day 1, 6 months and 1 year; however no patients experiences any adverse events</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sedation Only With Skin Conductance Monitor</title>
          <description>Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor</description>
        </group>
        <group group_id="E2">
          <title>Sedation &amp; Audiovisual Aids With Skin Conductance Monitor</title>
          <description>Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Danya DeMeo, Research Assistant</name_or_title>
      <organization>Hospital for Special Surgey</organization>
      <phone>2127742678</phone>
      <email>demeod@hss.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

